St. Elisabeth-Krankenhaus Köln-Hohenlind


Hospital

Location:
Köln, Germany


Publications in cooperation with FAU scientists


Eckstein, M., Wirtz, R.M., Pfannstil, C., Wach, S., Stoehr, R., Breyer, J.,... Erben, P. (2018). A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy. Oncotarget, 9(19), 15001-15014. https://dx.doi.org/10.18632/oncotarget.24531
Zinnall, U., Weyerer, V., Compérat, E., Camparo, P., Gaisa, N.T., Knuechel-Clarke, R.,... Bertz, S. (2018). Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype. Human Pathology. https://dx.doi.org/10.1016/j.humpath.2018.05.022
Eckstein, M., Wirtz, R.M., Gross-Weege, M., Breyer, J., Otto, W., Stoehr, R.,... Erben, P. (2018). mRNA-Expression of KRT5 and KRT20 Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants. International Journal of Molecular Sciences, 19(11). https://dx.doi.org/10.3390/ijms19113396
Breyer, J., Otto, W., Wirtz, R.M., Wullich, B., Keck, B., Erben, P.,... Hartmann, A. (2017). ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ. Urologia Internationalis, 98(3), 282-289. https://dx.doi.org/10.1159/000453670
Breyer, J., Wirtz, R.M., Otto, W., Erben, P., Kriegmair, M.C., Stoehr, R.,... Hartmann, A. (2017). In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival. Virchows Archiv, 470(3), 267-274. https://dx.doi.org/10.1007/s00428-017-2064-8
Breyer, J., Wirtz, R.M., Otto, W., Laible, M., Schlombs, K., Erben, P.,... Hartmann, A. (2017). Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsies. Oncotarget, 8(40), 67684-67695. https://dx.doi.org/10.18632/oncotarget.18804
Otto, W., Breyer, J., Herdegen, S., Eder, F., Bertz, S., May, M.,... Hartmann, A. (2017). WHO 1973 grade 3 and infiltrative growth pattern proved, aberrant E-cadherin expression tends to be of predictive value for progression in a series of stage T1 high-grade bladder cancer after organ-sparing approach. International Urology and Nephrology, 49(3), 431-437. https://dx.doi.org/10.1007/s11255-016-1491-9
Breyer, J., Wirtz, R.M., Laible, M., Schlombs, K., Erben, P., Kriegmair, M.C.,... Otto, W. (2016). ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC). Virchows Archiv, 469(5), 547-552. https://dx.doi.org/10.1007/s00428-016-2002-1
Wirtz, R.M., Fritz, V., Stoehr, R., & Hartmann, A. (2016). Molecular classification of bladder cancer. Possible similarities to breast cancer. Pathologe, 37(1), 52-60. https://dx.doi.org/10.1007/s00292-015-0134-8
Laible, M., Schlombs, K., Kaiser, K., Veltrup, E., Herlein, S., Lakis, S.,... Sahin, U. (2016). Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens. BMC Cancer, 16, 398. https://dx.doi.org/10.1186/s12885-016-2476-x

Last updated on 2017-22-07 at 06:24